Shares of San Diego drugmaker Zogenix Inc. (Nasdaq: ZGNX) surged Wednesday, as investors speculated that a delayed decision on the company's lead drug will lead to positive approval in coming weeks.
12400 High Bluff Dr. Ste., 650
San Diego, CA 92130
All contents herein copyright San Diego Source | The Daily Transcript ® 1994-2014